Search
for
Sort by
Research 211–240 of 1000+
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Endocrinology of Transgender Medicine
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Morpho-Regulation of Ectodermal Organs
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Targeting the Wnt pathways for therapies
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- What causes hidradenitis suppurativa ?—15 years after
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells
- Mice with Alopecia, Osteoporosis, and Systemic Amyloidosis Due to Mutation in Zdhhc13, a Gene Coding for Palmitoyl Acyltransferase
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- ROS Balance Autoregulating Core–Shell CeO2@ZIF-8/Au Nanoplatform for Wound Repair
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Nonsurgical Management of Facial Masculinization and Feminization
- Ruxolitinib for the treatment of severe alopecia areata
- Human hair keratins promote the regeneration of peripheral nerves in a rat sciatic nerve crush model
- Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for their Modes of Action in Hair Follicles
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- <i>Hedychium spicatum</i>: a systematic review on traditional uses, phytochemistry, pharmacology and future prospectus
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Hormonal therapies for acne
- The placebo effect and randomized trials: analysis of conventional medicine
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- Topically used herbal products for the treatment of hair loss: preclinical and clinical studies
- Adverse health effects of androgen use
- Biallelic HEPHL1 variants impair ferroxidase activity and cause an abnormal hair phenotype
- Group IID, IIE, IIF and III secreted phospholipase A2s